Immunovant
Krishna Patel has experience in quality engineering and validation. Currently, Krishna serves as the Director of Quality Engineering at Immunovant. Prior experience includes working as a Validation Engineer at CH2M HILL Lockwood Greene.
This person is not in any teams
This person is not in any offices
Immunovant
6 followers
Immunovant, Inc. is a clinical-stage biopharmaceutical company focused on enabling normal lives for patients with autoimmune diseases. Immunovant is developing IMVT-1401, a novel, fully human anti-FcRn monoclonal antibody, as a subcutaneous injection for the treatment of autoimmune diseases mediated by pathogenic IgG antibodies.